MediHerb
MediHerb Astragalus Complex 60 Tablets
MediHerb Astragalus Complex 60 Tablets
Regular price
$99.95
Regular price
Sale price
$99.95
Unit price
/
per
MediHerb Astragalus Complex contains astragalus, echinacea purpurea root, and Siberian ginseng. This combination of herbs provides temporary relief for the symptoms associated with the common cold, the flu, and infections in the upper respiratory tract.
Feature
- Echinacea root is traditionally used in Western herbal medicine to help stimulate a healthy immune system response and enhance immune system function
- Astragalus, Echinacea and Siberian Ginseng Support the immune system to fight illness
- Siberian Ginseng assists the body to cope with environmental stress, supports mental and physical capacity, and aids recovery from illness
Dose:
Adults: 1 tablet 2-4 times daily
Ingredients:
Each tablet contains: | |
Astragalus membranaceus (Astragalus) extract | 1.7 mL |
derived from root dry | 850 mg |
Eleutherococcus senticosus (Siberian Ginseng) extract | 75 mg |
derived from min. root dry | 750 mg |
standardised to contain syringaresinol glucosides | 600 mcg |
Echinacea purpurea (Echinacea) extract | 1.3 mL |
derived from root dry | 650 mg |
Calcium Hydrogen Phosphate Dihydrate, Colloidal Anhydrous Silica, Croscarmellose Sodium, Hypromellose, Magnesium Stearate, Microcrystalline Cellulose, Sodium Starch Glycollate.
No added: Gluten, soya bean, milk, lactose, peanuts, tree nuts, fish, crustacea, egg, sesame seeds, artificial sweeteners, colours or flavours
Suitable for vegans and vegetarians
Warning:
- Discontinue during an acute infectious illness or mild fever since the tonic and warming properties of Astragalus and Siberian Ginseng may aggravate the illness
- The risk of allergic reaction to Echinacea is very small, especially if root preparation is used since these are free of pollens.
- Echinacea is contraindicated in patients taking immunosuppressant medication (e.g. transplant patients). Therefore, short-term therapy only is suggested in this instance.
- Caution is advised in patients receiving midazolam by injection
- Not to be used in children under two years of age without medical advice
- Discontinue 7 days prior to general anaesthesia
- If patient symptoms persist, seek additional professional advice.